UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Public good diffusion limits microbial mutualism

Physical review letters, 2015-04, Vol.114 (16), p.168102, Article 168102

2015

Volltextzugriff (PDF)

Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers

Cell host & microbe, 2022-04, Vol.30 (4), p.583-598.e8

2022

Volltextzugriff (PDF)

Interactions between species introduce spurious associations in microbiome studies

PLoS computational biology, 2018-01, Vol.14 (1), p.e1005939-e1005939

2018

Volltextzugriff (PDF)

Microbiota profile in new-onset pediatric Crohn's disease: data from a non-Western population

Gut pathogens, 2018-11, Vol.10 (1), p.49-49, Article 49

2018

Volltextzugriff (PDF)

Bacterial dysbiosis predicts the diagnosis of Crohn's disease in Saudi children

Saudi journal of gastroenterology, 2021-05, Vol.27 (3), p.144-148

2021

Volltextzugriff (PDF)

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-04, Vol.329 (16), p.1356

2023

Volltextzugriff (PDF)

695 PHARMACODYNAMIC RESPONSE TO A DEFINED BACTERIAL CONSORTIUM, VE303, IN PATIENTS WITH CLOSTRIDIOIDES DIFFICILE INFECTION (CDI): RESULTS OF THE PHASE 2 CONSORTIUM STUDY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-140-S-141

2023

Volltextzugriff (PDF)

43 RECOVERY OF MICROBIOME FUNCTIONAL PATHWAYS INVOLVED IN STICKLAND FERMENTATION IN PATIENTS RECEIVING VE303, A DEFINED BACTERIAL CONSORTIUM FOR CLOSTRIDIOIDES DIFFICILE INFECTION (CDI)

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-17-S-17

2024

Volltextzugriff (PDF)

890: RAPID AND DURABLE COLONIZATION OF VE303 IN CLOSTRIDIODES DIFFICILE INFECTION (CDI) PATIENTS IS ASSOCIATED WITH CLINICAL EFFICACY: RESULTS OF THE PHASE 2 CONSORTIUM STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-217-S-217

2022

Volltextzugriff (PDF)

RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (3), p.S65-S66

2022

Volltextzugriff (PDF)

RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS

Inflammatory bowel diseases, 2022-01, Vol.28 (Supplement_1), p.S65-S66

2022

Volltextzugriff (PDF)

468: DURABLE COLONIZATION OF THE RATIONALLY DESIGNED LIVE BIOTHERAPEUTIC PRODUCTS VE202 AND VE818 IN HEALTHY VOLUNTEERS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-107-S-108

2022

Volltextzugriff (PDF)

2140. Biological Features of Response to VE303, a Defined Bacterial Consortium, in Patients with Clostridioides difficile Infection (CDI): Results from the Phase 2 CONSORTIUM Study

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

Network Topology and Community Function in Spatial Microbial Communities

Menon, Rajita

2018

Volltextzugriff (PDF)

Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study

Journal of Crohn's and colitis, 2024-09, Vol.18 (9), p.1381-1393

2024

Volltextzugriff (PDF)

Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease

World journal of gastroenterology : WJG, 2018-10, Vol.24 (39), p.4510-4516

2018

Volltextzugriff (PDF)

Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's Disease

Journal of Crohn's and colitis, 2017-05, Vol.11 (5), p.586-592

2017

Volltextzugriff (PDF)

1953. VE303, a Rationally Designed Bacterial Consortium for Prevention of Recurrent Clostridioides difficile (C. Difficile) infection (rCDI), Stably Restores the Gut Microbiota After Vancomycin (vanco)-Induced Dysbiosis in Adult Healthy Volunteers (HV)

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S60-S60

2019

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(17)
Dissertationen
(1)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Public good diffusion limits microbial mutualism

Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers

Interactions between species introduce spurious associations in microbiome studies

Microbiota profile in new-onset pediatric Crohn's disease: data from a non-Western population

Bacterial dysbiosis predicts the diagnosis of Crohn's disease in Saudi children

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial

695 PHARMACODYNAMIC RESPONSE TO A DEFINED BACTERIAL CONSORTIUM, VE303, IN PATIENTS WITH CLOSTRIDIOIDES DIFFICILE INFECTION (CDI): RESULTS OF THE PHASE 2 CONSORTIUM STUDY

43 RECOVERY OF MICROBIOME FUNCTIONAL PATHWAYS INVOLVED IN STICKLAND FERMENTATION IN PATIENTS RECEIVING VE303, A DEFINED BACTERIAL CONSORTIUM FOR CLOSTRIDIOIDES DIFFICILE INFECTION (CDI)

890: RAPID AND DURABLE COLONIZATION OF VE303 IN CLOSTRIDIODES DIFFICILE INFECTION (CDI) PATIENTS IS ASSOCIATED WITH CLINICAL EFFICACY: RESULTS OF THE PHASE 2 CONSORTIUM STUDY

RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS

RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS

468: DURABLE COLONIZATION OF THE RATIONALLY DESIGNED LIVE BIOTHERAPEUTIC PRODUCTS VE202 AND VE818 IN HEALTHY VOLUNTEERS

2140. Biological Features of Response to VE303, a Defined Bacterial Consortium, in Patients with Clostridioides difficile Infection (CDI): Results from the Phase 2 CONSORTIUM Study

Network Topology and Community Function in Spatial Microbial Communities

Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study

Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease

Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's Disease

1953. VE303, a Rationally Designed Bacterial Consortium for Prevention of Recurrent Clostridioides difficile (C. Difficile) infection (rCDI), Stably Restores the Gut Microbiota After Vancomycin (vanco)-Induced Dysbiosis in Adult Healthy Volunteers (HV)

Suchergebnisse filtern